Announcement of Meetings of the Tick-Borne Disease Working Group, 55845 [2017-25425]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 225 / Friday, November 24, 2017 / Notices
Availability of Materials: We will post
all meeting materials prior to the
meeting on the NPRSB December 7,
2017, meeting Web site located at
https://www.phe.gov/nprsb.
Procedures for Providing Public Input:
Members of the public attend by
teleconference via a toll-free call-in
phone number, which is available on
the NPRSB Web site at https://
www.phe.gov/nprsb.
We encourage members of the public
to provide written comments that are
relevant to the NPRSB teleconference
prior to December 7, 2017. Send written
comments by email to nprsb@hhs.gov
with ‘‘NPRSB Public Comment’’ in the
subject line. The NPRSB Chair will
respond to all comments received by
December 1, 2017, during the meeting.
Dated: November 15, 2017.
Robert P. Kadlec,
Assistant Secretary for Preparedness and
Response, Department of Health and Human
Services.
[FR Doc. 2017–25336 Filed 11–22–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of Meetings of the
Tick-Borne Disease Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS), in accordance
with Section 2062 of the 21st Century
Cures Act, announces the inaugural
meetings of the Tick-Borne Disease
Working Group (Working Group). For
these first meetings, Working Group
members will focus on plans to submit
a report to the Secretary of HHS and
Congress that is due December 2018.
The report will address a number of
issues related to tick-borne diseases,
including: Ongoing research; advances
in research; Federal activities; gaps in
research; the Working Group’s meetings;
and the comments received by the
Working Group. The report will also
include any recommendations to the
Secretary of Health and Human
Services. Planning will include
developing plans to solicit stakeholder
input and establish subcommittees.
Working Group members will also
determine how and when future
meetings will be conducted.
DATES: December 11, 2017, from 12:30
p.m. to 4:30 p.m., Eastern Time, and
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:19 Nov 22, 2017
Jkt 244001
December 12, 2017 from 9:00 a.m. to
4:30 p.m., Eastern Time.
ADDRESSES: Hubert H. Humphrey
Building, Great Hall, 200 Independence
Avenue SW., Washington, DC 20201;
via webcast at: https://www.hhs.gov/
ash/advisory-committees/tickborne
disease/.
FOR FURTHER INFORMATION CONTACT:
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov.
SUPPLEMENTARY INFORMATION: Members
of the public may attend the meetings in
person or via webcast at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/.
In-person attendance at the meetings
is limited to space available; therefore
preregistration for public members is
advisable and can be accomplished by
registering at https://events.r20.constant
contact.com/register/event?llr=
zz7zptzab&oeidk=a07edrodfu088eae0cf
by Friday, December 8, 2017. On the
day of the meetings, seating will be
provided first to persons who have
preregistered. People who have not
preregistered will be accommodated on
a first come, first served basis if
additional seats are still available 10
minutes before the meetings start. NonU.S. citizens who plan to attend in
person are required to provide
additional information and must notify
the Working Group support staff via
email at tickbornedisease@hhs.gov
before November 30, 2017. Members of
the public who wish to attend the
meetings should enter from
Independence Avenue. Please allow
extra time to get through security.
The Working Group invites public
comment on issues related to the
Working Group’s charge. It may be
provided in-person at the meetings or in
writing. Persons who wish to provide
public comment in person should
submit a request to do so via email at
tickbornedisease@hhs.gov on or before
December 1, 2017. In-person comments
will be limited to three minutes each to
accommodate as many speakers as
possible. A total of 60 minutes will be
allocated to public comment and may be
divided between the two days of
meetings. If more requests are received
than can be accommodated, speakers
will be randomly selected. The nature of
the comments will not be considered in
making this selection.
Public comment may also be provided
in writing only. Individuals who would
like to provide written public comment
should send their comments to
PO 00000
Frm 00047
Fmt 4703
Sfmt 9990
55845
tickbornedisease@hhs.gov on or before
December 6, 2017.
Meeting information is available at
the group’s Web page: https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/ or by
contacting the Working Group via email
at tickbornedisease@hhs.gov to request
additional information.
Purpose of Meetings: Working Group
members will focus on plans to submit
a report to the Secretary of HHS and
Congress that is due December 2018.
The report will address a number of
issues related to tick-borne diseases,
including: Ongoing research; advances
in research; Federal activities; gaps in
research; the Working Group’s meetings;
and the comments received by the
Working Group. The report will also
include any recommendations to the
Secretary of Health and Human
Services. Planning will include
developing plans to solicit stakeholder
input and establish subcommittees.
Working Group members will also
determine how and when future
meetings will be conducted.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with Section 2062 of the
21st Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review all HHS efforts related to tickborne diseases to help ensure
interagency coordination and minimize
overlap, examine research priorities,
and identify and address unmet needs.
The Working Group will submit a report
to the Secretary of HHS and Congress on
issues related to tick-borne diseases,
including: Ongoing research: Advances
in research: Federal activities; gaps in
research; the Working Group’s meetings;
and the comments by the Working
Group.
Structure, Membership, and
Operation: The Working Group consists
of 14 members selected to represent a
diverse range of stakeholder
perspectives. Seven members were
nominated and selected from the public,
and seven members, or their designees,
represent federal agencies doing this
work. A roster of Working Group
members is available at the Working
Group’s Web page: https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/.
Dated: November 15, 2017.
Richard Wolitski,
Director, Office of HIV/AIDS and Infectious
Disease Policy, Designated Federal Officer,
Tick-Borne Disease Working Group.
[FR Doc. 2017–25425 Filed 11–22–17; 8:45 am]
BILLING CODE 4150–28–P
E:\FR\FM\24NON1.SGM
24NON1
]]>Agencies
[Federal Register Volume 82, Number 225 (Friday, November 24, 2017)]
[Notices]
[Page 55845]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-25425]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Announcement of Meetings of the Tick-Borne Disease Working Group
AGENCY: Office of HIV/AIDS and Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Health and Human Services (HHS), in
accordance with Section 2062 of the 21st Century Cures Act, announces
the inaugural meetings of the Tick-Borne Disease Working Group (Working
Group). For these first meetings, Working Group members will focus on
plans to submit a report to the Secretary of HHS and Congress that is
due December 2018. The report will address a number of issues related
to tick-borne diseases, including: Ongoing research; advances in
research; Federal activities; gaps in research; the Working Group's
meetings; and the comments received by the Working Group. The report
will also include any recommendations to the Secretary of Health and
Human Services. Planning will include developing plans to solicit
stakeholder input and establish subcommittees. Working Group members
will also determine how and when future meetings will be conducted.
DATES: December 11, 2017, from 12:30 p.m. to 4:30 p.m., Eastern Time,
and December 12, 2017 from 9:00 a.m. to 4:30 p.m., Eastern Time.
ADDRESSES: Hubert H. Humphrey Building, Great Hall, 200 Independence
Avenue SW., Washington, DC 20201; via webcast at: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/.
FOR FURTHER INFORMATION CONTACT: James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the Assistant Secretary for
Health, Department of Health and Human Services; via email at
tickbornedisease@hhs.gov.
SUPPLEMENTARY INFORMATION: Members of the public may attend the
meetings in person or via webcast at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/.
In-person attendance at the meetings is limited to space available;
therefore preregistration for public members is advisable and can be
accomplished by registering at https://events.r20.constantcontact.com/register/event?llr=zz7zptzab&oeidk=a07edrodfu088eae0cf by Friday,
December 8, 2017. On the day of the meetings, seating will be provided
first to persons who have preregistered. People who have not
preregistered will be accommodated on a first come, first served basis
if additional seats are still available 10 minutes before the meetings
start. Non-U.S. citizens who plan to attend in person are required to
provide additional information and must notify the Working Group
support staff via email at tickbornedisease@hhs.gov before November 30,
2017. Members of the public who wish to attend the meetings should
enter from Independence Avenue. Please allow extra time to get through
security.
The Working Group invites public comment on issues related to the
Working Group's charge. It may be provided in-person at the meetings or
in writing. Persons who wish to provide public comment in person should
submit a request to do so via email at tickbornedisease@hhs.gov on or
before December 1, 2017. In-person comments will be limited to three
minutes each to accommodate as many speakers as possible. A total of 60
minutes will be allocated to public comment and may be divided between
the two days of meetings. If more requests are received than can be
accommodated, speakers will be randomly selected. The nature of the
comments will not be considered in making this selection.
Public comment may also be provided in writing only. Individuals
who would like to provide written public comment should send their
comments to tickbornedisease@hhs.gov on or before December 6, 2017.
Meeting information is available at the group's Web page: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/ or by
contacting the Working Group via email at tickbornedisease@hhs.gov to
request additional information.
Purpose of Meetings: Working Group members will focus on plans to
submit a report to the Secretary of HHS and Congress that is due
December 2018. The report will address a number of issues related to
tick-borne diseases, including: Ongoing research; advances in research;
Federal activities; gaps in research; the Working Group's meetings; and
the comments received by the Working Group. The report will also
include any recommendations to the Secretary of Health and Human
Services. Planning will include developing plans to solicit stakeholder
input and establish subcommittees. Working Group members will also
determine how and when future meetings will be conducted.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with Section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. App., as amended, to provide expertise and review all HHS
efforts related to tick-borne diseases to help ensure interagency
coordination and minimize overlap, examine research priorities, and
identify and address unmet needs. The Working Group will submit a
report to the Secretary of HHS and Congress on issues related to tick-
borne diseases, including: Ongoing research: Advances in research:
Federal activities; gaps in research; the Working Group's meetings; and
the comments by the Working Group.
Structure, Membership, and Operation: The Working Group consists of
14 members selected to represent a diverse range of stakeholder
perspectives. Seven members were nominated and selected from the
public, and seven members, or their designees, represent federal
agencies doing this work. A roster of Working Group members is
available at the Working Group's Web page: https://www.hhs.gov/ash/advisory-committees/tickbornedisease/.
Dated: November 15, 2017.
Richard Wolitski,
Director, Office of HIV/AIDS and Infectious Disease Policy, Designated
Federal Officer, Tick-Borne Disease Working Group.
[FR Doc. 2017-25425 Filed 11-22-17; 8:45 am]
BILLING CODE 4150-28-P
